Thermo Fisher Scientific Inc. opened its new $90 million viral vector CDMO (contract development and manufacturing organization) site in Lexington, MA. The 50,000-square-foot facility will add more than 200 jobs and support the development, testing and manufacture of viral vectors, which are critical to advancing gene and cell therapies globally.  “Thermo Fisher’s investment in both the regional economic development of the Commonwealth and its commitment to furthering STEM educati...